SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-126454
Filing Date
2024-11-13
Accepted
2024-11-13 16:57:56
Documents
12
Reference 429
333-275700

Document Format Files

Seq Description Document Type Size
1 S-3 engene_secondary_s-3_nov.htm S-3 961043
2 EX-5.1 engn-ex5_1.htm EX-5.1 35035
3 EX-23.1 engn-ex23_1.htm EX-23.1 3149
4 EX-23.2 engn-ex23_2.htm EX-23.2 4864
5 EX-99.1 engn-ex99_1.htm EX-99.1 435100
6 EX-99.2 engn-ex99_2.htm EX-99.2 627420
7 EX-99.3 engn-ex99_3.htm EX-99.3 370417
8 EX-FILING FEES engn-exfiling_fees.htm EX-FILING FEES 69551
9 GRAPHIC img50421859_0.jpg GRAPHIC 88425
10 GRAPHIC img50421859_1.jpg GRAPHIC 7716
11 GRAPHIC img93391562_0.jpg GRAPHIC 19311
12 GRAPHIC img93391562_1.jpg GRAPHIC 19311
  Complete submission text file 0000950170-24-126454.txt   2693727
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: S-3 | Act: 33 | File No.: 333-283202 | Film No.: 241455371
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)